TRANSESOPHAGEAL ECHOCARDIOGRAPHY - 11/09/11
Résumé |
The presentation of the critically ill patient encompasses numerous idiosyncrasies and complexities. The correct diagnosis is crucial and must be made in an expeditious fashion to avert an ever-pressing morbidity or mortality. Current technology is not always helpful and can be misleading for the correct diagnosis (e.g., information from the pulmonary artery catheter [PAC]) and monitoring of these critically ill patients.250 Transesophageal echocardiography (TEE) is not a new technology but an evolving and explosive one, and it should be one of the diagnostic tools for the intensivist.* As the proportion of in-house acutely ill patients increases in an environment of health-care reform, the multidisciplinary critical care physician continues to play a major role in the total care of these patients. The use of TEE is part of the physician's armamentarium and should complement the role of transthoracic echocardiography (TTE).83, 335
The benefits of TEE over TTE comprise several major advantages. Because the placement of the probe is retrocardiac via the esophagus, adjacent cardiac and extracardiac structures are easily visualized with excellent resolution (higher frequency). Typically, in the intensive care patient, inadequate imaging via the TTE approach is common (e.g., obesity or underlying pulmonary disease or mechanical interference by dressings, tapes, or thoracostomy tubes). In addition, the position of the TEE probe can be manipulated or maintained easily in one position depending on the condition in question (diagnosis versus monitoring). It is not infrequent in our practice to initiate the evaluation from the esophageal approach. For complete appreciation of the detailed anatomic correlates of the images, the author defers to other texts (Figure 1, Figure 4, Figure 5, Figure 6).17, 80, 91, 150, 238, 266
The indications for the use of TEE in the intensive care setting are not that indifferent for the cardiologist, rather than the proportion and prime indicators. In the intensive care setting, the indications are ventricular function, including ventricular performance, right and left heart interactions, preload assessment, ischemic heart disease and its complications; aortic pathology—aortic dissection and aneurysm, aortic trauma-periaortic hematoma or transection or tear, and aortic debris (as a source for emboli); valvular heart disease (native or prosthetic); intracardiac or extracardiac masses (either vegetations or thrombi), including pulmonary embolism; and intracardiac shunts—patent foramen ovale (as a conduit for emboli or contributor for refractory hypoxia) and congenital or acquired defects (following penetrating trauma).89, 122, 151, 220, 224, 225, 234, 237, 239, 339
The contraindications are few but must be appreciated with any procedure. The absolute contraindications are any esophageal pathologic condition such as strictures, recent esophageal or gastric surgery, esophageal hemorrhage or bleeding varices, neoplasm, or recent penetrating trauma. Relative contraindications are systemic sclerosis, chest wall radiation, esophageal varices (TEE is increasingly used during orthotopic liver transplantation), or an uncooperative patient. After review of history and physical, a gastroenterologist should be consulted if suspect esophageal pathology exists.*
There are some risks in the TEE examination, ranging from esophageal bleeding, tears, laryngospasm, aspiration, hypoxia, bronchospasm, congestive heart failure, and dysrhythmias to mechanical difficulties (in children) such as
Midesophageal view. Longitudinal and transverse imaging with transesophageal echocardiography. LA=left atrium; LV=left ventricle; RA= right atrium; RV=right ventricle; AML=anterior mitral leaflet; PML=posterior mitral leaflet; CS= coronary sinus; PV=pulmonary vein; S=superior; I=inferior; A=anterior; P=posterior; IVC=inferior vena cava; SVC=superior vena cava. (From Porembka DT: Transesophageal echocardiography and cardiac critical care. In Williams JP (ed): Postoperative Management of the Cardiac Surgical Patient. New York, Churchill Livingstone, in press; with permission.)
Figure 2 Midesophageal view. Longitudinal and transverse imaging with transesophageal echocardiography. LA=left atrium; LV=left ventricle; RA= right atrium; RV=right ventricle; AML=anterior mitral leaflet; PML=posterior mitral leaflet; CS= coronary sinus; PV=pulmonary vein; S=superior; I=inferior; A=anterior; P=posterior; IVC=inferior vena cava; SVC=superior vena cava. (From Porembka DT: Transesophageal echocardiography and cardiac critical care. In Williams JP (ed): Postoperative Management of the Cardiac Surgical Patient. New York, Churchill Livingstone, in press; with permission.) transtracheal placement or bronchial obstruction or aortic compression. In two large series, the major complications are reported to approximate 0.18% to 0.5% of cases studied with two fatalities.60, 148 Because there is a high benefit:risk ratio, TEE is gaining popularity outside the echocardiography suite and operating room area to the intensive care and emergency department settings. The impact is dramatic in determining the underlying pathologic condition. Medical or surgical interventions are undertaken from the information obtained during the examination; at times, management is altered.
The future of echocardiography encompasses miniaturization of probes, even the development of intracardiac echocardiography and PAC technology. In addition, software advancements will incorporate algorithms for regional wall motion analysis, three-dimensional volume reconstruction, pressure/volume relationships, and tissue characterization for perfusion. All of these improvements will affect the intensivist and the care of their patients for accurate, real-time diagnosis and monitoring. This article discusses the benefits and the efficacy of TEE for the intensivist and the perioperative physician. Some of the discussion reviews the evolving technology and its impact, keeping in mind the multidisciplinary team approach.
Base of the heart. Transverse imaging with transesophageal echocardiography. AO=aorta; LA=left atrium; LAA=left atrial appendage; LLPV=left lower pulmonary vein; LUPV=left upper pulmonary vein; FO=fossa ovalis; LCA=left coronary artery; MPA=main pulmonary artery; PV=pulmonary vein; RA=right atrium; RAA=right atrial appendage; RCA=right coronary artery; RLPV=right lower pulmonary vein; RPA=right pulmonary artery; RUPV= right upper pulmonary vein; RV=right ventricle; SVC=superior vena cava. (From Porembka DT: Transesophageal echocardiography and cardiac critical care. In Williams JP (ed): Postoperative Management of the Cardiac Surgical Patient. New York, Churchill Livingstone, in press; with permission.)
Figure 3 Base of the heart. Transverse imaging with transesophageal echocardiography. AO=aorta; LA=left atrium; LAA=left atrial appendage; LLPV=left lower pulmonary vein; LUPV=left upper pulmonary vein; FO=fossa ovalis; LCA=left coronary artery; MPA=main pulmonary artery; PV=pulmonary vein; RA=right atrium; RAA=right atrial appendage; RCA=right coronary artery; RLPV=right lower pulmonary vein; RPA=right pulmonary artery; RUPV= right upper pulmonary vein; RV=right ventricle; SVC=superior vena cava. (From Porembka DT: Transesophageal echocardiography and cardiac critical care. In Williams JP (ed): Postoperative Management of the Cardiac Surgical Patient. New York, Churchill Livingstone, in press; with permission.) Le texte complet de cet article est disponible en PDF.
Plan
| Address reprint requests to David T. Porembka, DO, FCCM, Department of Anesthesia, University of Cincinnati College of Medicine, PO Box 670531, Cincinnati, OH 45267-0531 |
Vol 12 - N° 4
P. 875-918 - octobre 1996 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
